US2010323010A1PendingUtilityA1
Formulation and process for drug loaded cores
Est. expiryJul 11, 2023(expired)· nominal 20-yr term from priority
A61K 31/00A61P 9/12A61K 9/2077A61K 9/1676A61K 31/137
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a controlled release pellet of metoprolol and its pharmaceutically acceptable salts that uses a water soluble or a water swellable inert starting seed or core.
Claims
exact text as granted — not AI-modified1 - 65 . (canceled)
66 . A controlled release metoprolol succinate tablet comprising:
(a) 15-60 wt % based upon the total weight of the tablet of a plurality of controlled release metoprolol succinate pellets; (b) 1-15 wt % based upon the total weight of the tablet of an immediate release dose of metoprolol succinate; (c) 20-70 wt % based upon the total weight of the tablet of a disintegrant and/or cushioning agent; and (d) 5-40 wt % based upon the total weight of the tablet of a lubricant, wherein the tablet exhibits the following dissolution profile when tested in a USP Type 2 apparatus at 75 rpms, 37° C. in a phosphate buffer medium with a pH of 7.5:
10-40% of the metoprolol is released after 2 hours;
20-50% of the metoprolol is released after 4 hours;
35-70% of the metoprolol is released after 8 hours; and
not less than 60% of the metoprolol is released after 16 hours.
67 . The controlled release tablet as defined in claim 66 wherein the disintegrant and/or cushioning agent is selected from the group consisting of microcrystalline cellulose, lactose, crospovidone, sodium starch glycolate and mixtures thereof.
68 . The controlled release tablet as defined in claim 66 wherein the lubricant is glyceryl monostearate.
69 . The controlled release tablet as defined in claim 66 wherein the controlled release pellets pass through a 25 mesh screen and are retained on an 80 mesh screen.
70 . The controlled release tablet as defined in claim 69 wherein the controlled release pellets comprise:
(i) a water soluble inert core having a diameter of less than 30 mesh;
(ii) a drug layer applied to the inert core comprising: metoprolol succinate; a binder; and optionally a surfactant; and
(iii) a controlled release coating applied to the drug layer comprising a water insoluble film forming polymer.
71 . A controlled release metoprolol succinate tablet comprising:
(a) 15-60 wt % based upon the total weight of the tablet of a plurality of controlled release metoprolol succinate pellets wherein the controlled release pellets pass through a 25 mesh screen and are retained on an 80 mesh screen and further comprise
(i) a water soluble inert core having a diameter of less than 30 mesh;
(ii) a drug layer applied to the inert core comprising: metoprolol succinate; a binder selected from the group consisting of polyvinyl pyrrolidone, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, polyacrylate, ethylcellulose or mixture thereof; and optionally a surfactant; and
(iii) a controlled release coating applied to the drug layer comprising:
50-95 wt % based upon the total weight of the controlled release coating of a water insoluble film forming polymer;
0-25 wt % based upon the total weight of the controlled release coating of an emulsifier; and
0-15 wt % based upon the total weight of the controlled release coating of a channeling agent;
(b) 1-15 wt % based upon the total weight of the tablet of an immediate release dose of metoprolol succinate; (c) 20-70 wt % based upon the total weight of the tablet of a disintegrant and/or cushioning agent selected from the group consisting of microcrystalline cellulose, lactose, crospovidone, sodium starch glycolate and mixtures thereof; and (d) 5-40 wt % based upon the total weight of the tablet of a lubricant, wherein the tablet exhibits the following dissolution profile when tested in a USP Type 2 apparatus at 75 rpms, 37° C. in a phosphate buffer medium with a pH of 7.5:
10-40% of the metoprolol is released after 2 hours;
20-50% of the metoprolol is released after 4 hours;
35-70% of the metoprolol is released after 8 hours; and
not less than 60% of the metoprolol is released after 16 hours.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.